NCT00753168View on ClinicalTrials.gov

Phase 1-2 Evaluation of OT-730 Eye Drops in Reducing the Intraocular Pressure in Patients With Ocular Hypertension or Open-Angle Glaucoma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

48

Participants

Timeline

Start Date

September 30, 2008

Primary Completion Date

December 31, 2008

Study Completion Date

December 31, 2008

Conditions
Glaucoma, Open-AngleOcular Hypertension
Interventions
DRUG

OT-730 ophthalmic solution

one eye drop twice daily

DRUG

timolol maleate ophthalmic solution

one eye drop twice daily

DRUG

OT-730 placebo

one eye drop twice daily

Trial Locations (5)

Unknown

Artesia

Roswell

Charlotte

High Point

Mt. Pleasant

Sponsors
All Listed Sponsors
lead

Othera Pharmaceuticals

INDUSTRY